Hearing Loss Among HIV-Seropositive and HIV-Seronegative Men and Women

被引:29
|
作者
Torre, Peter, III [1 ]
Hoffman, Howard J. [2 ]
Springer, Gayle [3 ]
Cox, Christopher [3 ]
Young, Mary A. [4 ]
Margolick, Joseph B. [5 ]
Plankey, Michael [4 ]
机构
[1] San Diego State Univ, Sch Speech Language & Hearing Sci, San Diego, CA 92182 USA
[2] NIDCD, Epidemiol & Stat Program, NIH, Bethesda, MD USA
[3] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA
[5] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
NUTRITION EXAMINATION SURVEY; MULTICENTER AIDS COHORT; ANTIRETROVIRAL THERAPY; ACOUSTIC CHARACTERISTICS; DIABETES-MELLITUS; NATIONAL-HEALTH; INFECTION; ASSOCIATION; PREVALENCE; ADULTS;
D O I
10.1001/jamaoto.2014.3302
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Age-related hearing loss affects quality of life. Data on hearing loss among aging human immunodeficiency virus-seropositive (HIV+) adults are limited. OBJECTIVE To evaluate pure-tone hearing thresholds among HIV+ and HIV-seronegative (HIV-) adults and to determine whether HIV disease variables and antiretroviral therapy are associated with pure-tone threshold levels. DESIGN, SETTING, AND PARTICIPANTS A total of 262 men (117 HIV+) from the Baltimore, Maryland/Washington, DC, site of the Multicenter AIDS Cohort Study and 134 women (105 HIV+) from the Washington, DC, site of the Women's Interagency HIV Study participated. Pure-tone air conduction thresholds were collected in a sound-treated room for each ear at frequencies from 250 through 8000 Hz. Linear mixed regression models tested the effect of HIV on hearing after adjustment for age, sex, race, and noise exposure history. MAIN OUTCOMES AND MEASURES Low-frequency pure-tone average (LPTA) at 250, 500, 1000, and 2000 Hz and high-frequency PTA (HPTA) at 3000, 4000, 6000, and 8000 Hz. Differential HIV effects for LPTA and HPTA and better/worse ear were also examined. CD4(+) and CD8(+) T-cell counts, log(10) plasma HIV RNA concentrations, receipt of AIDS diagnosis, and cumulative duration of antiretroviral therapy were included in the models for HIV+ participants only. RESULTS HPTA and LPTA were significantly higher (18%: estimated ratio, 1.18 [95% CI, 1.02-1.36]; P=.02; and 12%: estimated ratio, 1.12 [95% CI, 1.00-1.26]; P=.05, respectively) for HIV+ participants compared with HIV-participants for the better ear. The direction of the effect was consistent across both the better and worse ears. There were no significant associations between HIV disease variables or treatment variables and LPTA or HPTA. CONCLUSIONS AND RELEVANCE The HIV+ adults had significantly poorer lower-frequency and higher-frequency hearing than HIV-adults. High-frequency hearing loss is consistent with an accelerated aging (presbycusis); low-frequency hearing loss in middle age is unexpected. Because some vowels and consonants have predominantly low-frequency acoustic energy, poor low-frequency hearing may impair communication in HIV+ individuals.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [1] THE PREVALENCE OF HEARING SENSITIVITY AMONG HIV-SEROPOSITIVE AND HIV-SERONEGATIVE MEN AND WOMEN
    Plankey, M. W.
    Hoffman, H. J.
    Springer, G.
    Cox, C.
    Young, M. A.
    Margolick, J. B.
    Torre, P.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A124 - A124
  • [2] Cochlear Function Among HIV-Seropositive and HIV-Seronegative Men and Women
    Torre, Peter, III
    Hoffman, Howard J.
    Springer, Gayle
    Cox, Christopher
    Young, Mary
    Margolick, Joseph B.
    Plankey, Michael
    EAR AND HEARING, 2014, 35 (01): : 56 - 62
  • [3] Prevalence of Abnormalities in Vestibular Function and Balance among HIV-Seropositive and HIV-Seronegative Women and Men
    Cohen, Helen S.
    Cox, Christopher
    Springer, Gayle
    Hoffman, Howard J.
    Young, Mary A.
    Margolick, Joseph B.
    Plankey, Michael W.
    PLOS ONE, 2012, 7 (05):
  • [4] Pregnancy interval and delivery outcome among HIV-seropositive and HIV-seronegative women in Kisumu, Kenya
    van Eijk, AM
    De Cock, KM
    Ayisi, JG
    Rosen, DH
    Otieno, JA
    Nahlen, BL
    Steketee, RW
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (01) : 15 - 24
  • [5] Associations between dietary antioxidant intake and oxidative stress in HIV-seropositive and HIV-seronegative men and women
    McDermid, JM
    Lalonde, RG
    Gray-Donald, K
    Baruchel, S
    Kubow, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (02) : 158 - 164
  • [6] Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults
    Feldman, C
    Glatthaar, M
    Morar, R
    Mahomed, AG
    Kaka, S
    Cassel, M
    Klugman, KP
    CHEST, 1999, 116 (01) : 107 - 114
  • [7] TUBERCULIN AND ANERGY TESTING IN HIV-SEROPOSITIVE AND HIV-SERONEGATIVE PERSONS
    MARKOWITZ, N
    HANSEN, NI
    WILCOSKY, TC
    HOPEWELL, PC
    GLASSROTH, J
    KVALE, PA
    MANGURA, BT
    OSMOND, D
    WALLACE, JM
    ROSEN, MJ
    REICHMAN, LB
    ANNALS OF INTERNAL MEDICINE, 1993, 119 (03) : 185 - 193
  • [8] Ethnicity, Serostatus, and Psychosocial Differences in Sexual Risk Behavior Among HIV-Seropositive and HIV-Seronegative Women
    Keisha Carr Paxton
    Hector F. Myers
    Naomi M. Hall
    Marjan Javanbakht
    AIDS and Behavior, 2004, 8 : 405 - 415
  • [9] Ethnicity, serostatus, and psychosocial differences in sexual risk behavior among HIV-seropositive and HIV-seronegative women
    Paxton, KC
    Myers, HF
    Hall, NM
    Javanbakht, M
    AIDS AND BEHAVIOR, 2004, 8 (04) : 405 - 415
  • [10] Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women
    Koshiol, Jill
    Schroeder, Jane
    Jamieson, Denise J.
    Marshall, Stephen W.
    Duerr, Ann
    Heilig, Charles M.
    Shah, Keerti V.
    Klein, Robert S.
    Cu-Uvin, Susan
    Schuman, Paula
    Celentano, David
    Smith, Jennifer S.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (02) : 176 - 183